sibutramine has been researched along with Binge Eating in 5 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this randomized, double-blind, placebo-controlled study, the effect of sibutramine and cognitive-behavioural weight loss (cognitive-BWL) treatment was assessed in obese subjects with and without subclinical binge eating disorder (sBED)." | 9.12 | Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder. ( Bauer, C; Fischer, A; Keller, U, 2006) |
| "Seven adult subjects who had problems with binge eating (mean age, 42 years) were randomly assigned to receive alternating sibutramine and placebo in a double-blind placebo-controlled crossover study." | 9.10 | Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm. ( Burgard, MA; Crosby, RD; de Zwaan, M; Gosnell, BA; Mitchell, JE; Roerig, JL; Wambach, BN; Wonderlich, SA, 2003) |
| "In this randomized, double-blind, placebo-controlled study, the effect of sibutramine and cognitive-behavioural weight loss (cognitive-BWL) treatment was assessed in obese subjects with and without subclinical binge eating disorder (sBED)." | 5.12 | Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder. ( Bauer, C; Fischer, A; Keller, U, 2006) |
| "Seven adult subjects who had problems with binge eating (mean age, 42 years) were randomly assigned to receive alternating sibutramine and placebo in a double-blind placebo-controlled crossover study." | 5.10 | Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm. ( Burgard, MA; Crosby, RD; de Zwaan, M; Gosnell, BA; Mitchell, JE; Roerig, JL; Wambach, BN; Wonderlich, SA, 2003) |
| "Although antidepressants are the pharmacological agents most often studied in the treatment of binge-eating disorder (BED), preliminary evidence from an open trial suggests that the antiobesity agent sibutramine hydrochloride may be effective." | 5.10 | A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. ( Appolinario, JC; Bacaltchuk, J; Claudino, AM; Coutinho, W; Godoy-Matos, A; Morgan, C; Sichieri, R; Zanella, MT, 2003) |
| "Treatment with sibutramine, 15 mg/day, was administered for 12 weeks." | 2.70 | An open-label trial of sibutramine in obese patients with binge-eating disorder. ( Appolinario, JC; Cabral, M; Carraro, L; Coutinho, W; Fontenelle, LF; Godoy-Matos, A; Vieira, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cifani, C | 1 |
| Polidori, C | 1 |
| Melotto, S | 1 |
| Ciccocioppo, R | 1 |
| Massi, M | 1 |
| Mitchell, JE | 1 |
| Gosnell, BA | 1 |
| Roerig, JL | 1 |
| de Zwaan, M | 1 |
| Wonderlich, SA | 1 |
| Crosby, RD | 1 |
| Burgard, MA | 1 |
| Wambach, BN | 1 |
| Appolinario, JC | 2 |
| Bacaltchuk, J | 1 |
| Sichieri, R | 1 |
| Claudino, AM | 1 |
| Godoy-Matos, A | 2 |
| Morgan, C | 1 |
| Zanella, MT | 1 |
| Coutinho, W | 2 |
| Bauer, C | 1 |
| Fischer, A | 1 |
| Keller, U | 1 |
| Fontenelle, LF | 1 |
| Carraro, L | 1 |
| Cabral, M | 1 |
| Vieira, A | 1 |
4 trials available for sibutramine and Binge Eating
| Article | Year |
|---|---|
Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm.
Topics: Adult; Appetite Depressants; Bulimia; Cross-Over Studies; Cyclobutanes; Double-Blind Method; Eating; | 2003 |
A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
Topics: Adolescent; Adult; Antidepressive Agents; Appetite Depressants; Body Weight; Bulimia; Cyclobutanes; | 2003 |
Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder.
Topics: Adolescent; Adult; Aged; Appetite Depressants; Bulimia; Cognitive Behavioral Therapy; Combined Modal | 2006 |
An open-label trial of sibutramine in obese patients with binge-eating disorder.
Topics: Adult; Anxiety Disorders; Appetite Depressants; Bulimia; Comorbidity; Cyclobutanes; Depressive Disor | 2002 |
1 other study available for sibutramine and Binge Eating
| Article | Year |
|---|---|
A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam.
Topics: Animals; Appetite Depressants; Behavior, Animal; Bulimia; Cyclobutanes; Disease Models, Animal; Eati | 2009 |